Navigation Links
Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
Date:6/15/2009

SAN DIEGO, June 15 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today that it will present preclinical data from its LPA1 receptor antagonist program on June 30, 2009 at the Federation of American Societies for Experimental Biology (FASEB) Summer Research Conference in Carefree, Arizona.

The LPA1 receptor is part of the Phosphatidic Acid/Lysophosphatidylcholine pathway, which among other things is associated with cell to cell communication. In recent studies, it has been shown to potentially play a role in fibrotic disease, specifically Idiopathic Pulmonary Fibrosis (IPF).

"Our data not only confirms that this pathway may play a role in fibrotic diseases such as IPF, but that we are well on our way to developing an orally available antagonist which could be studied in a human clinical setting," said Peppi Prasit, Ph.D., Chief Scientific Officer. "While a great deal of work remains on this program, we are particularly excited since we believe this could be a novel, first-in-class therapy."

Bob Baltera, Chief Executive Officer, added, "Our LPA1 program is particularly important for Amira. IPF is a specialty focused disease setting and presents the opportunity for Amira to develop a therapeutic through commercialization without the assistance of a strategic partner. Most importantly, IPF is a grievous disease with minimally effective therapeutic options for patients today."

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

Amira has a partnership w
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
2. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
3. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
4. Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
5. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
6. Amira Pharmaceuticals Appoints First Vice President of Development
7. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
8. Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study
9. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
10. Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results
11. Isis Pharmaceuticals to Present at Jefferies 3rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 The muscles in the human ... and one of the biggest and most significant nervous ... The peripheral system comprises of peripheral nerves that reside ... nerves ensure that the limbs and hands, as well ... nerves get damaged due to trauma or physical injury, ...
(Date:5/19/2013)... 6Webs.com is the leader in reviews ... are considering an alarm system can do a comparison ... security system providers online at 6Webs.com. Just recently finishing ... home security system companies, 6Webs.com currently is announcing ... home security companies before ranking the home security system ...
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... a Case Management Conference was recently convened for hundreds ... federal multidistrict litigation now underway in U.S. District Court, ... on the Court’s website on May 14th, the Conference ... It was also reported during the Conference that Defendants ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn Stevenson ... people get in shape, and gain a healthy life regardless ... is a natural fat loss system that provides people with ... fat loss diet program claimed that The Fat Loss Code ... body fat off long-term. After Shawn Stevenson launched this new ...
(Date:5/19/2013)... May 19, 2013 Exciting new Skin ... is reintroducing a great practice known through the ages ... known as dry body brushing, has so many benefits ... of Sublime Beauty®. "We love that circulation and lymphatic ... largest organ, the skin, is supported through Skin Brushing." ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2
... electromagnetic radiation research center feel, that we need ... level radiowaves. Radiowaves and microwaves play an increasing role ... and personal digital assistants, pagers, and text messengers. ... of their existence. In other words, we are bathed ...
... University of Texas, offer provide some valuable tips on how to ... you might find it hard to maintain a flat stomach. Some ... abdominal area. Or, if you have lost height as you've got ... depend on doing hundreds of sit-ups. All round general exercise is ...
... most common encountered among the mountaineers. Doctors have new ... altitude sickness and others are not. They say two ... increase the risk of high altitude sickness.// , ... people climb higher than 8,000 feet. It is a ...
... Despite the fact that doctors know the power of a ... and heart failure, many patients do not take the medications. ... attack// can reduce the risk of early death by 20 ... fatigue and sexual dysfunction and, therefore, do not take the ...
... heat to destroy cancerous tissue assists patients with advanced ... of heat to destroy malignant tissue. Including liver tumours, ... types.,Now researchers at Montefiore Medical Center, New York, report// ... neck cancer. The group of patients were not candidates ...
... biting a bar of chocolate every day is connected to ... fat and sugar, it has long been seen as a ... based products, it also contains antioxidants, which can protect from ... now suggest that people who eat chocolate regularly are happier ...
Cached Medicine News:
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... company overview at the UBS Global Healthcare Conference in ... Wednesday, May 22 nd at 11 a.m. Eastern Time. ... the presentation, please visit the Investor Relations section of the ... be available for 14 days after the event. ...
(Date:5/17/2013)... DIEGO and CAMBRIDGE, Mass., May 17, 2013 /PRNewswire/ ... that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) ... Court for the District of Massachusetts ... its officers violated the Securities Exchange Act of 1934 ... 1, 2013 (the "Class Period"). (Logo: ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... aspirator is intended for destruction and removal ... operative interventions in the field of a ... In an operational zone in a consequence ... with liquid environment interaction arises cavitational processes. ...
... Dissectron ultrasonic aspirator, portable ... surgical aspirator for the ... tissue available only outside ... in a very compact ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Medicine Products: